Oncolytics Biotech Inc.

447 articles with Oncolytics Biotech Inc.

• Oncolytics Biotech Announces 2017 First Quarter Results

  5/5/2017

• Oncolytics Biotech Announces Details Of 2017 Annual Meeting Of Shareholders

  4/27/2017

• Oncolytics Biotech Announces Registration Pathway And Clinical Development Plan

  4/12/2017

• Oncolytics Biotech’s REOLYSIN More Than Doubles Overall Survival in Patients With Mutated p53 Metastatic Breast Cancer

  4/5/2017

• Oncolytics Biotech Inc.'s REOLYSIN Provides Statistically Significant Improvement In Overall Survival In Canadian Cancer Trials Group Sponsored Randomized Phase II Study In Metastatic Breast Cancer

  4/3/2017

• Oncolytics Biotech Inc. Enters Into First-In-Class Collaboration With Myeloma UK And Celgene Using REOLYSIN In Combination With Imnovid Or Revlimid In Patients With Myeloma

  3/16/2017

• Oncolytics Biotech Inc. Announces 2016 Year-End Results

  3/10/2017

• Oncolytics Biotech Inc. Release: Company Appoints Dr. Matt Coffey To The Role Of President And CEO

  1/19/2017

• Oncolytics Biotech Inc. Announces Change To Board Of Directors

  12/7/2016

• Oncolytics Biotech Inc. Collaborators Present Initial Results From REO 019 Study In Multiple Myeloma Combining REOLYSIN, Bortezomib And Dexamethasone At The American Society of Hematology Annual Meeting

  12/6/2016

• Oncolytics Biotech Inc. Announces Appointment Of New Chief Medical Officer

  11/10/2016

• Oncolytics Biotech Inc. Announces 2016 Third Quarter Results

  11/2/2016

• Oncolytics Biotech Inc. Announces Participation In The 4th Annual Immuno-Oncology Summit

  8/30/2016

• MEDIA ADVISORY - Oncolytics Biotech Inc. Announces Participation In The Canaccord Genuity 36th Annual Growth Conference

  8/11/2016

• Oncolytics Biotech Inc. Reports Additional Data From Randomized Phase II Study Of REOLYSIN In Non-Small Cell Lung Cancer

  8/10/2016

• Oncolytics Biotech Inc. Announces 2016 Second Quarter Results

  8/4/2016

• Oncolytics Biotech Inc. Announces Phase 2 Study In Female Patients With Colorectal Cancer Metastatic To The Liver

  6/29/2016

• Oncolytics Biotech Inc. Announces Voting Results From Its Annual Meeting Of Shareholders

  5/6/2016

• Oncolytics Biotech Inc. Announces 2016 First Quarter Results

  5/6/2016

• Oncolytics Biotech Inc. Announces Presentation Of REOLYSIN Preclinical Research At The 2016 ASGCT Annual Meeting

  5/5/2016